Clotting involves a chain-reaction of biologically active proteins in the body.
This "coagulation cascade" culminates in formation of fibrin, a substance that is the bulk of clots. However, clots are also comprised of platelets
, a type of blood cell that adheres to the fibrin. Anticoagulants specifically inhibit steps in the chain-reaction of proteins, whereas anti-platelets inhibit these cells.